Home
Conditions
Lymphoma, Large-Cell, Diffuse

Clinical trial condition

Lymphoma, Large-Cell, Diffuse

Explore clinical trials studying Lymphoma, Large-Cell, Diffuse. Study availability and eligibility vary by location and protocol.

10 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

Lymphoma, Large-Cell, Diffuse trial results

Enrolling by Invitation

A Multicenter, Prospective, Randomized, Controlled Study of Decitabine in Combination With R-CHOP for Initial Treatment of EBV+ Diffuse Large B-cell Lymphoma

NCT07348575

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: The Second Affiliated Hospital of Nanchang University Nanchang, Jiangxi, China

View Trial Details

Completed

A Study of Two Associations of Rituximab and Chemotherapy, With a PET-driven Strategy, in Lymphoma

NCT00498043

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: René Olivier Casasnovas Dijon, France

View Trial Details

Completed

R-ICE Versus R-DHAP in Patients Aged 18-65 With Relapse Diffuse Large B-cell Lymphoma

NCT00137995

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: Memorial Sloan Kettering Cancer Center New York, United States

Australian leukemia and lymphoma group Sydney, Australia

Groupe d'atude des lymphome de l'adulte Yvoir, Belgium

Czech Lymphoma study group Prague, Czechia

View Trial Details

Completed

Ofatumumab Versus Rituximab Salvage Chemoimmunotherapy Followed by Autologous Stem Cell Transplant in Relapsed or Refractory Diffuse Large B Cell Lymphoma

NCT01014208

Conditions: Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
Locations: GSK Investigational Site Sacramento, California, United States

GSK Investigational Site New Haven, Connecticut, United States

GSK Investigational Site Chicago, Illinois, United States

GSK Investigational Site Chicago, Illinois, United States

View all 173 locations

View Trial Details

Completed

Ofatumumab in Patients With Relapsed/Progressive Diffused Large B-Cell Lymphoma (DLBCL) Ineligible for or Relapse/Progression After Transplant

NCT00622388

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: GSK Investigational Site London, United Kingdom

View Trial Details

Completed

Diffuse Large B Cell Lymphoma of the Adult: Randomization Between High Dose Chemotherapy With Rituximab and CHOP 14-Rituximab

NCT00561379

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: Nantes University Hospital Nantes, France

View Trial Details

Completed

Bortezomib Plus CHOP Every 2 Weeks for Advanced Stage DLBCL

NCT00379574

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: Asan Medical Center, University of Ulsan College of Medicine Seoul, South Korea

Asan Medical Cener Seoul, South Korea

View Trial Details

Completed

Phase II Study of Ofatumumab Plus Ifosfamide, Carboplatin, Etoposide (ICE) or Dexamethasone, Cytarabine, Cisplatin (DHAP) Chemotherapy Regimen in Relapsed/ Refractory Diffuse Large B Cell Lymphoma (DLBCL)

NCT00823719

Conditions: Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
Locations: Not specified

View Trial Details

Completed

Pilot Protocol for the Treatment of Patients With Small Non-Cleaved and Diffuse Large Cell Lymphomas

NCT00001237

Conditions: Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +17 more
Locations: National Cancer Institute (NCI) Bethesda, Maryland, United States

View Trial Details

Completed

ACVBP Followed by ASCT in Patients With BCL-2 Positive Diffuse Large B-Cell Lymphoma

NCT00169130

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: Service d'Hematologie Mont-Godinne, Belgium

Hôpital Henri Mondor Créteil, France

Hôpital Saint Louis Paris, France

Centre Hospitalier Lyon Sud Pierre-Bénite, France

View Trial Details

Lymphoma, Large-Cell, Diffuse

Lymphoma, Large-Cell, Diffuse trial results

Related conditions